12-Month Lobbying Summary - In-house Organization

Novo Nordisk Canada Inc. / Vince Lamanna, President

Registration Summary

Active - Last Updated: 2024-09-02

Who is lobbying?

Novo Nordisk Canada Inc. (Address, activities & membership)

Vince Lamanna, President

Received government funding or funding expected in current financial year

What is being lobbied?

Subject Matter Details

Details Regarding the Identified Subject Matter
Subject matters	Details	Categories
Health, Research and Development	Advocate for the establishment of public-private partnerships to support chronic disease prevention.	Policies or Program
Health	Advocate for the implementation of a federal diabetes and obesity strategy.	Policies or Program
Health	Bill C-64, the Pharmacare Act, with respect to definitional questions related to terms contained in Section 6.1, and concerns regarding the increased risk of drug shortages.	Legislative Proposal, Bill or Resolution
Health, International Trade	Communication around existing drug shortages and shared solutions to mitigate the impact on Canadians.	Policies or Program
Health, Research and Development, Science and Technology	Support the establishment of a life sciences strategy in Canada	Policies or Program

Subject matter details in previous versions

Details Regarding the Identified Subject Matter
Subject matters	Details	Categories
Subject matters were not required to be associated with subject matter details when this content was submitted	Advocate for the establishment of public-private partnerships to support chronic disease prevention.	Policies or Program
Subject matters were not required to be associated with subject matter details when this content was submitted	Advocate for the implementation of a federal diabetes and obesity strategy.	Policies or Program
Subject matters were not required to be associated with subject matter details when this content was submitted	Communication around existing drug shortages and shared solutions to mitigate the impact on Canadians	Regulation
Subject matters were not required to be associated with subject matter details when this content was submitted	Support the establishment of a life sciences strategy in Canada	Policies or Program

Subject matters in previous versions

Aboriginal Affairs
Arts and Culture
Budget
Economic Development
Employment and Training
Health
Industry
Intellectual Property
Internal Trade
International Development
International Relations
International Trade
Regional Development
Research and Development
Science and Technology

Who is being lobbied?

Government Institutions

Agriculture and Agri-Food Canada (AAFC)
Canada Foundation for Innovation
Canadian Heritage (PCH)
Canadian Human Rights Tribunal (CHRT)
Canadian Institutes of Health Research (CIHR)
Employment and Social Development Canada (ESDC)
Finance Canada (FIN)
Global Affairs Canada (GAC)
Health Canada (HC)
House of Commons
Indigenous Services Canada (ISC)
Innovation, Science and Economic Development Canada (ISED)
National Research Council (NRC)
Parks Canada (PC)
Patented Medicine Prices Review Board (PMPRB)
Prime Minister's Office (PMO)
Privy Council Office (PCO)
Public Health Agency of Canada (PHAC)
Senate of Canada
Treasury Board Of Canada Secretariat (TBS)

Communication techniques

Communication techniques that have been used or are expected to be used in the course of the undertaking:

Written communication
Oral communication

Who are the lobbyists?

Gabrielle Berard, Senior Manager, External Affairs | Designated public offices held
Michael Tucker, Patient Access Manager, Atlantic | No public offices held

Registration number: 954988-360616
View all registrations versions

Monthly Communication Reports

What oral and arranged communications have taken place?

What oral and arranged communications have taken place?
Date	DPOH, Position Title \| Government Institution	Subject Matters
2024-10-08	Linsey Hollett, Assistant Deputy Minister \| Regulatory, Operations and Enforcement Branch, Health Canada (HC)	Health, International Trade
2024-10-02	Scott Tannas, Senator Senate of Canada	Health
2024-09-24	Michelle Boudreau, Associate Assistant Deputy Minister Health Canada (HC) Ya'ara Saks, Minister of Mental Health and Addictions, Associate Minister of Health Health Canada (HC)	Health
2024-09-24	Shuvaloy Majumdar, Member of Parliament House of Commons	Health
2024-09-24	Corey Tochor, Member of Parliament House of Commons	Health
2024-09-23	Ritu Bannerjee, Assistant Deputy Minister \| Office of Life Sciences and Biomanufacturing Readiness, Innovation, Science and Economic Development Canada (ISED)	Health, Research and Development
2024-09-23	Christiana Osei, Digital Media and Communications Advisor \| Office of the Minister of Small Business, Innovation, Science and Economic Development Canada (ISED) Ajay Rakhra, Senior Advisor, Ontario and Stakeholder Relations \| Office of the Minister of Small Business, Innovation, Science and Economic Development Canada (ISED) Rechie Valdez, Minister of Small Business Innovation, Science and Economic Development Canada (ISED) Chris Zhou, Director of Policy (Acting) \| Office of the Minister of Small Business, Innovation, Science and Economic Development Canada (ISED)	Health
2024-09-23	Adam Chambers, Member of Parliament House of Commons	Health
2024-08-08	Eshan Naik, Director of Policy \| Office of the Minister of Health, Health Canada (HC)	Health
2024-07-22	Matthew Trnkus, Policy Advisor \| Office of the Minister of Foreign Affairs, Global Affairs Canada (GAC)	Health, International Trade
2024-07-17	Andrew Cardozo, Senator Senate of Canada	Health
2024-07-15	Chelios Vuong, Policy Advisor \| Office of the Minister of Foreign Affairs, Global Affairs Canada (GAC)	Health, International Trade
2024-07-09	Jeremy Bruce, Deputy Director, Policy \| Office of the Minister of Foreign Affairs, Global Affairs Canada (GAC)	Health, International Trade
2024-06-05	Judith Seidman, Senator Senate of Canada	Health
2024-05-23	Blaine Calkins, Member of Parliament \| Red Deer—Lacombe, House of Commons Earl Dreeshen, Member of Parliament \| Red Deer—Mountain View, House of Commons Stephen Ellis, Member of Parliament, Cumberland-Colchester House of Commons Tom Kmiec, Member of Parliament \| Calgary Shepard, House of Commons	Health, Research and Development, Science and Technology
2024-03-27	Sharon Burey, Senator Senate of Canada	Health
2024-03-19	Randy Hoback, Member of Parliament House of Commons	Health, International Trade
2024-03-13	Jade Mallette, Director of Parliamentary Affairs \| Office of the Minister of Health, Health Canada (HC)	Health
2024-02-28	Shuvaloy Majumdar, Member of Parliament House of Commons	Health

View all monthly communication reports

Novo Nordisk Canada Inc. - Address, activities & membership

Address:

101-2476 Argentia Road
Mississauga, ON L5N 6M1
Canada

Telephone number: 905-629-4222

Contact information in previous versions
- 101-2476 Argentia Road
  Mississauga, ON L5N 6M1
  Canada
  
  Telephone number: 905-691-2208
- 2680 Skymark Avenue
  Mississauga, ON L4W 5L6
  Canada
  
  Telephone number: 905-691-2208

Description of the organization's activities:
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease.

Descriptions of the organization's activity in previous versions:
- At Novo Nordisk, we are driving change to defeat diabetes and other serious chronic conditions. Novo Nordisk Canada Inc. is an affiliate of Novo Nordisk A/S, a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: hemophilia, growth disorders and obesity.
- Novo Nordisk Canada Inc. is a global leader in the development of therapies for diabetes, metabolic diseases and blood disorders. Novo Nordisk’s innovations in diabetes cover both the treatment as well as devices, and we are working hard to find a cure for diabetes and, short of that, to completely reduce diabetes as an obstacle to a healthy and productive life.

Organization's membership or classes of membership:
Novo Nordisk employs about 57,100 people in 80 countries and markets its products in around 170 countries.

Organization's memberships or classes of memberships in previous versions:
- Headquartered in Denmark, Novo Nordisk employs approximately 41,600 people in 80 countries and markets its products in 170 countries.
- Innovative Medicines Canada BIOTECanada Life Sciences Ontario Mississauga Board of Trade
- Innovative Medicines Canada BIOTECanada Life Sciences Ontario

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Director of Parliamentary Affairs Parliament of Canada, Senate of Canada	August 2017 to August 2018	Not a designated office
Policy Advisor Finance Canada, Office of the Minister of Finance	October 2011 to November 2014	November 21, 2014

Date Modified:: 2024-12-05

Search and menus

Language selection